1417 related articles for article (PubMed ID: 17041749)
1. Indication and benefit of pelvic sidewall dissection for rectal cancer.
Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.
Kobayashi H; Mochizuki H; Kato T; Mori T; Kameoka S; Shirouzu K; Sugihara K
Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054
[TBL] [Abstract][Full Text] [Related]
3. [Clinic study of lateral lymph node metastasis in advanced lower rectal cancer].
Wu ZY; Wan J; Yao Y; Zhao G; Du JL; Yang J
Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):190-2. PubMed ID: 18683713
[TBL] [Abstract][Full Text] [Related]
4. Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period.
Ishiguro S; Akasu T; Fujita S; Yamamoto S; Kusters M; Moriya Y
Surgery; 2009 Feb; 145(2):189-95. PubMed ID: 19167974
[TBL] [Abstract][Full Text] [Related]
5. Who can get the beneficial effect from lateral lymph node dissection for Dukes C rectal carcinoma below the peritoneal reflection?
Sato H; Maeda K; Maruta M; Masumori K; Koide Y
Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S3-12. PubMed ID: 17106812
[TBL] [Abstract][Full Text] [Related]
6. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
Kneist W; Heintz A; Wolf HK; Junginger T
Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
[TBL] [Abstract][Full Text] [Related]
7. Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method.
Hida J; Yasutomi M; Fujimoto K; Maruyama T; Okuno K; Shindo K
J Am Coll Surg; 1997 May; 184(5):475-80. PubMed ID: 9145067
[TBL] [Abstract][Full Text] [Related]
8. What factors affect lymph node yield in surgery for rectal cancer?
Thorn CC; Woodcock NP; Scott N; Verbeke C; Scott SB; Ambrose NS
Colorectal Dis; 2004 Sep; 6(5):356-61. PubMed ID: 15335370
[TBL] [Abstract][Full Text] [Related]
9. [Lateral pelvic lymph node metastasis is an important prognostic factor for low rectal cancer].
Pan YS; Wan YL; Liu YC; Wang X; Wu T
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):984-7. PubMed ID: 19957807
[TBL] [Abstract][Full Text] [Related]
10. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
11. Oncologic results of laparoscopic D3 lymphadenectomy for male sigmoid and upper rectal cancer with clinically positive lymph nodes.
Liang JT; Huang KC; Lai HS; Lee PH; Sun CT
Ann Surg Oncol; 2007 Jul; 14(7):1980-90. PubMed ID: 17458586
[TBL] [Abstract][Full Text] [Related]
12. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
13. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
14. [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection].
Li CS; Wan DS; Pan ZZ; Zhou ZW; Chen G; Wu XJ; Li LR; Lu ZH; Ding PR; Li Y
Ai Zheng; 2006 May; 25(5):587-90. PubMed ID: 16687079
[TBL] [Abstract][Full Text] [Related]
15. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
[TBL] [Abstract][Full Text] [Related]
17. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence.
Akasu T; Takawa M; Yamamoto S; Ishiguro S; Yamaguchi T; Fujita S; Moriya Y; Nakanishi Y
Ann Surg Oncol; 2008 Oct; 15(10):2668-76. PubMed ID: 18618181
[TBL] [Abstract][Full Text] [Related]
18. Lateral lymph node dissection for lower rectal cancer.
Shiozawa M; Akaike M; Yamada R; Godai T; Yamamoto N; Saito H; Sugimasa Y; Takemiya S; Rino Y; Imada T
Hepatogastroenterology; 2007 Jun; 54(76):1066-70. PubMed ID: 17629040
[TBL] [Abstract][Full Text] [Related]
19. Metastasis to the sigmoid or sigmoid mesenteric lymph nodes from rectal cancer.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg; 2009 Jun; 249(6):960-4. PubMed ID: 19474698
[TBL] [Abstract][Full Text] [Related]
20. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.
Ueno M; Oya M; Azekura K; Yamaguchi T; Muto T
Br J Surg; 2005 Jun; 92(6):756-63. PubMed ID: 15838895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]